Delivery Order SPE2DB22D3301-SPE2DB25FY7UT
Award Date 7/14/25
Potential Completion Date 7/15/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,392.59 to AmerisourceBergen Drug Corp for Lamotrigine ER 100 mg tablets (30-count supply) on August 26, 2025, with completion expected by August 27, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,357.64 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 300 mg tablets (30-count units) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 50 mg tablets in quantities of 30 units, with a ceiling value of $4,276.80. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the place of performance for this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,701.36 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 250 mg tablets in quantities of 30 units. This award, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lamotrigine ER 200 mg tablets in a 30-count package, with a ceiling value of $1,516.80 and a firm fixed price structure. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime contract vehicle valued through December 2026 that provides...
- The Defense Logistics Agency awarded a delivery order valued at $1,910.41 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 250 mg tablets (30-count packages). This contract, awarded on August 5, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.28 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price, competitively awarded delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lamotrigine ER 300 mg tablets (30-count units) valued at $1,750.97. This competitive, non-set-aside delivery order is categorized as firm fixed price and is scheduled for completion by October 28, 2025, with performance at the contractor's Conshohocken, Pennsylvania headquarters. The award represents a continuation of AmerisourceBergen's significant role in supporting...
- The Defense Logistics Agency awarded a delivery order valued at $5,426.01 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count) on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Lamotrigine ER 100 mg tablets in quantities of 30 units, with a ceiling value of $1,163.95. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 4, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open competition among...